Exerpt from the latest Patrick Cox email on the info in the recent PR about the on-going thyroid study.
Nevertheless, it's clear that with the data that's already available from 48 of 165 subjects, the treated and untreated test subjects are showing significant differences. Moreover, the interleukins associated with thyroiditis are presumably reduced, as they were in the animal studies.
I believe, therefore, that the human thyroiditis results are going to be similar to those of the already completed animal thyroiditis study. That study, showing significant amelioration of thyroiditis, was historic, as nothing else has ever demonstrated reversal of thyroid disease.
He's referring to this verbiage from the PR...
“The raters who reviewed the data agreed that there were sufficiently large enough intertreatment differences, in both anti-thyroid antibody and interleukins, that the study was likely to reach its designed objectives. The statistical team that conducted the interim look recommended continuing the study as planned, and the company anticipates completion and data base lock in December 2012.”
